News & Articles

Explore topics from LC-MS for oligos, peptides, glycans, and large molecule characterization to 3D cell culture for anticancer therapies

KSQ Therapeutics uses technology created at MIT to study the role of every human gene in disease biology

New, reversible CRISPR method can control gene expression while leaving underlying DNA sequence unchanged

Vaccine, trialed in 450 children, shows favorable safety profile and was well-tolerated

COVID-19 infections fell by 65% percent after a first dose of the Oxford-AstraZeneca or Pfizer-BioNTech vaccines in this large community surveillance study

A new Prenetics Innovation Technology Centre will be established for advanced molecular diagnostics

First rapid antigen test with performance data on children

Sensor could be used in discovering new treatments for mental illness, in neuroscience research and to detect drugs of abuse

Anti-cancer drug delivery to target tumor sites now becomes more effective with novel multi-stimuli-responsive drug delivery systems

An insider’s view on leveraging the latest single-cell technologies, including cell sorting and single-cell sequencing, to understand what drives response or resistance in checkpoint therapies

The company will receive up to $5 million in grant funds from DARPA as part of the agency’s Nucleic Acids On-Demand World-Wide Program to plan for and prevent the next viral pandemic

The MDC Lighthouse Lab in Cheshire, which plays a key role in the UK Government’s COVID-19 testing rollout, has announced it has processed its 10 millionth test

Dr. Tania Nolan outlines how her team is designing assays to identify new variants and why these are critical to managing the global response

The test offers 98.0% clinical sensitivity for samples with PCR Ct values up to 31

The Ultreon 1.0 Software helps physicians automatically detect and quantify blood vessel characteristics, giving them better insights for optimal patient treatment

Each line of ValuPanel Reagents consists of separately delivered probes and primers, which allow assay flexibility and sizes that can help facilitate scale-up

AI could hold the key to more targeted treatment, according to new research